Catalyst Wire Dossier Catalyst Wire Dossier

Carbinoxamine maleate extended-release oral suspension

carbinoxamine maleate · Neos Therapeutics, LP
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Carbinoxamine maleate extended-release oral suspension, covering 2013-03-28 to 2026-03-10. Get the full timeline:

Most recent: FDA Approved: CARBINOXAMINE MALEATE EXTENDED-RELEASE ORAL SUSPENSION — Supplemental Application (Neos Therapeutics, LP)

See pricing